Building a reproducible single-cell sequencing workflow to capture tumour persistence
The ultimate goal of the PERSIST-SEQ consortium is to improve the understanding of therapeutic resistance in cancer and create effective strategies to improve cancer treatment and prevent drug resistance.
Consortium
14 European partners
Budget
14 million Euros
Project duration
5 years
Start date
1 July 2021